The report below gives a good overview of the Summer 2022 M&A activity in the Healthcare & Life Sciences Industry Sector. The Healthcare & Life Sciences market continues to expand rapidly due to the development of new therapeutic areas, adoption of digital and technological advancements, standardization of clinical studies, government initiatives aimed at modernizing the regulatory framework, and improvements in approval processes and reimbursement policies. However, the ongoing Russia-Ukraine conflict, and supply chain challenges concerning raw materials such as aluminum, titanium, nickel, and gases used in medical devices such as surgical and orthopedic devices and implants are causing headwinds in the medical devices and pharmaceutical market. Additionally medical equipment market is also expected to receive less investments during the second half of 2022, due to recessionary fears, as per report published by Medtech dive. Nevertheless, compared to other service industries, healthcare is typically more resilient to general economic shocks. In June 2022, the US Consumer Price Index increased by 9.1% over 2021, while the US Health Care Price Index increased by 2.0%. It is expected that the healthcare & life sciences market would grow rapidly in the future due to increased incidences of chronic diseases such as diabetes and cancer, the growing geriatric population, and the adoption of advanced technology.
Posted by Daniel Sirvent.